For instance, there was a significant correlation between PI3K/IGF1 gene set signature scores and high PRR11 mRNA levels in clinical cohorts of ER+ breast tumors treated with neoadjuvant letrozole. This evidence concerns the gene PRR11 and breast neoplasm.